Understanding the potentiality of accelerator based-boron neutron capture therapy for osteosarcoma: dosimetry assessment based on the reported clinical experience

BACKGROUND: Osteosarcoma is the most frequent primary malignant bone tumour, and its incidence is higher in children and adolescents, for whom it represents more than 10% of solid cancers. Despite the introduction of adjuvant and neo-adjuvant chemotherapy that markedly increased the success rate in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bortolussi, Silva, Postuma, Ian, Protti, Nicoletta, Provenzano, Lucas, Ferrari, Cinzia, Cansolino, Laura, Dionigi, Paolo, Galasso, Olimpio, Gasparini, Giorgio, Altieri, Saverio, Miyatake, Shin-Ichi, González, Sara J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557419/
https://www.ncbi.nlm.nih.gov/pubmed/28806981
http://dx.doi.org/10.1186/s13014-017-0860-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557419/
https://www.ncbi.nlm.nih.gov/pubmed/28806981
http://dx.doi.org/10.1186/s13014-017-0860-6

Ejemplares similares